富满微 reported revenue of ¥0.68B for the period ended 2026-06-30, +77.0% year on year. Net income was ¥0.09B, a 13.4% net margin on a 26.1% gross margin. The largest revenue line is LED灯、LED控制及驱动类芯片 at 45% of the total. Free cash flow for the period was ¥-0.07B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.68B | +77.0% |
| Gross profit | ¥0.18B | — |
| Operating income | ¥0.10B | — |
| Net income | ¥0.09B | — |
| Gross margin | 26.1% | Net margin 13.4% |
| Revenue Q/Q | +51.9% | — |
| Segment | Revenue | Share |
|---|---|---|
| LED灯、LED控制及驱动类芯片 | ¥0.30B | 44.6% |
| 电源管理类芯片 | ¥0.17B | 25.1% |
| 其他类芯片 | ¥0.14B | 20.1% |
| MOSFET类芯片 | ¥0.07B | 10.1% |
| 其他(补充) | ¥0.00B | 0.1% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.50B | 73.9% |
| R&D | ¥0.06B | 8.8% |
| SG&A | ¥0.03B | 5.1% |
| Tax & other | ¥0.01B | 1.6% |
| Item | Amount |
|---|---|
| Total assets | ¥3.00B |
| Total liabilities | ¥1.33B |
| Shareholders' equity | ¥1.67B |
| Equity / assets | 55.6% |
| Operating cash flow | ¥-0.05B |
| Capital expenditure | ¥0.01B |
| Free cash flow | ¥-0.07B |
| Cash conversion (OCF / net income) | -116% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
国科微 ・ 佩蒂股份 ・ 宇信科技 ・ 建科院 ・ 华大基因 ・ 英科医疗 ・ 中科信息 ・ 电连技术 ・ 隆盛科技 ・ 英搏尔 ・ 朗新科技 ・ 海特生物
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies